1. Home
  2. MSA vs MIRM Comparison

MSA vs MIRM Comparison

Compare MSA & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MSA Safety Incorporated

MSA

MSA Safety Incorporated

HOLD

Current Price

$171.93

Market Cap

6.7B

Sector

Health Care

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$94.28

Market Cap

5.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSA
MIRM
Founded
1914
2018
Country
United States
United States
Employees
5300
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.7B
5.7B
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
MSA
MIRM
Price
$171.93
$94.28
Analyst Decision
Buy
Strong Buy
Analyst Count
5
12
Target Price
$197.40
$115.33
AVG Volume (30 Days)
205.3K
702.8K
Earning Date
05-04-2026
05-06-2026
Dividend Yield
1.22%
N/A
EPS Growth
N/A
74.59
EPS
N/A
N/A
Revenue
N/A
$19,138,000.00
Revenue This Year
$6.78
$26.22
Revenue Next Year
$5.00
$22.04
P/E Ratio
$28.18
N/A
Revenue Growth
N/A
N/A
52 Week Low
$147.68
$39.18
52 Week High
$208.92
$109.28

Technical Indicators

Market Signals
Indicator
MSA
MIRM
Relative Strength Index (RSI) 48.84 48.08
Support Level $166.79 $85.35
Resistance Level $175.73 $98.03
Average True Range (ATR) 4.58 3.39
MACD 1.16 0.06
Stochastic Oscillator 67.89 20.06

Price Performance

Historical Comparison
MSA
MIRM

About MSA MSA Safety Incorporated

MSA Safety Inc makes safety products that are used to protect workers in the oil and gas and mining industries. The company's product offerings include breathing apparatuses, fall protection, portable gas detection systems, industrial head protection, fire and rescue helmets, and fixed gas and flame detection systems, among others. The end markets for its products include the fire service, contractor, industrial, mining, oil and gas, and utilities industries. The company has organized its business into four geographical operating segments that are aggregated into two reportable segments: Americas and International. The majority of its revenue is generated from the Americas segment, which is comprised of the company's operations in Northern North America and Latin America geographies.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing therapies for rare and orphan diseases. Its main product, Livmarli (maralixibat), is an orally administered IBAT inhibitor approved to treat cholestatic pruritus in patients with Alagille syndrome. The company is also developing treatments such as maralixibat for PFIC and ALGS, and volixibat for adult cholestatic liver diseases. Mirum currently has three approved medicines: Livmarli, Cholbam, and Ctexli.

Share on Social Networks: